Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.46 |
| ▸ | FAAH | O00519 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20087368 | 0.89 | MGLL (0.54) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL10064443 | 0.83 | MGLL (0.59) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL4887536 | 0.76 | MGLL (0.56) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL155453 | 0.72 | MGLL (0.52) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL17537362 | 0.72 | CYP3A4 (0.41) | NPSR1 | |
| SCHEMBL4859512 | 0.70 | MGLL (0.54) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14678413 | 0.69 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL145737 | 0.69 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL24740916 | 0.67 | MGLL (0.62) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL420429 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362276-B2 | Reacting a vinyl sulfone compound with imide compound in presence of catalyst | INKTEC CO., LTD. (KR) | 2013-01-29 | — | — | US | disclosed |
| US-8362276-B2 | Reacting a vinyl sulfone compound with imide compound in presence of catalyst | INKTEC CO., LTD. (KR) | 2013-01-29 | — | — | US | disclosed |
| US-8362276-B2 | Reacting a vinyl sulfone compound with imide compound in presence of catalyst | INKTEC CO., LTD. (KR) | 2013-01-29 | — | — | US | disclosed |
| US-20080262243-A1 | Beta-Sulfone Imides and Preparation Thereof | INKTEC CO., LTD. (KR) | 2008-10-23 | — | — | US | disclosed |
| US-20080262243-A1 | Beta-Sulfone Imides and Preparation Thereof | INKTEC CO., LTD. (KR) | 2008-10-23 | — | — | US | disclosed |
| US-20080262243-A1 | Beta-Sulfone Imides and Preparation Thereof | INKTEC CO., LTD. (KR) | 2008-10-23 | — | — | US | disclosed |
| WO-2006107175-A1 | BETA-SULFONE IMIDES AND PREPARATION THEREOF | INKTEC CO., LTD. (KR) | 2006-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262243-A1 | Beta-Sulfone Imides and Preparation Thereof | STS, CBS, SI | MGLL 4376/4885FAAH 2794/4885ALDH1A1 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.